協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/12/10 | 2,072 | 2,101 | 2,054 | 2,082 | -20 | -1% | 1,477,000 |
| 2015/12/09 | 2,144 | 2,150 | 2,096 | 2,102 | -47 | -2.2% | 1,421,000 |
| 2015/12/08 | 2,198 | 2,206 | 2,136 | 2,149 | -60 | -2.7% | 1,550,000 |
| 2015/12/07 | 2,215 | 2,225 | 2,205 | 2,209 | +28 | +1.3% | 673,000 |
| 2015/12/04 | 2,200 | 2,227 | 2,176 | 2,181 | -68 | -3% | 1,233,000 |
| 2015/12/03 | 2,300 | 2,304 | 2,242 | 2,249 | -44 | -1.9% | 1,473,000 |
| 2015/12/02 | 2,210 | 2,310 | 2,201 | 2,293 | +77 | +3.5% | 2,526,000 |
| 2015/12/01 | 2,168 | 2,216 | 2,144 | 2,216 | +47 | +2.2% | 1,689,000 |
| 2015/11/30 | 2,150 | 2,189 | 2,122 | 2,169 | -9 | -0.4% | 3,773,000 |
| 2015/11/27 | 2,195 | 2,195 | 2,136 | 2,178 | -20 | -0.9% | 1,640,000 |
| 2015/11/26 | 2,207 | 2,224 | 2,194 | 2,198 | +1 | ±0% | 993,000 |
| 2015/11/25 | 2,190 | 2,207 | 2,176 | 2,197 | -3 | -0.1% | 1,318,000 |
| 2015/11/24 | 2,165 | 2,208 | 2,165 | 2,200 | +29 | +1.3% | 1,529,000 |
| 2015/11/20 | 2,123 | 2,171 | 2,106 | 2,171 | +29 | +1.4% | 1,857,000 |
| 2015/11/19 | 2,102 | 2,159 | 2,101 | 2,142 | +70 | +3.4% | 1,579,000 |
| 2015/11/18 | 2,111 | 2,116 | 2,063 | 2,072 | -13 | -0.6% | 1,276,000 |
| 2015/11/17 | 2,052 | 2,103 | 2,040 | 2,085 | +57 | +2.8% | 1,814,000 |
| 2015/11/16 | 2,006 | 2,043 | 1,995 | 2,028 | -14 | -0.7% | 1,592,000 |
| 2015/11/13 | 2,081 | 2,088 | 2,025 | 2,042 | -63 | -3% | 1,904,000 |
| 2015/11/12 | 2,079 | 2,125 | 2,070 | 2,105 | +23 | +1.1% | 1,035,000 |
| 2015/11/11 | 2,071 | 2,118 | 2,068 | 2,082 | -39 | -1.8% | 2,011,000 |
| 2015/11/10 | 2,073 | 2,124 | 2,061 | 2,121 | +28 | +1.3% | 1,092,000 |
| 2015/11/09 | 2,081 | 2,103 | 2,066 | 2,093 | +28 | +1.4% | 1,227,000 |
| 2015/11/06 | 2,038 | 2,072 | 2,017 | 2,065 | +21 | +1% | 1,053,000 |
| 2015/11/05 | 2,009 | 2,060 | 2,003 | 2,044 | +54 | +2.7% | 1,366,000 |
| 2015/11/04 | 1,991 | 2,031 | 1,983 | 1,990 | +39 | +2% | 1,226,000 |
| 2015/11/02 | 1,972 | 1,981 | 1,941 | 1,951 | -51 | -2.5% | 1,340,000 |
| 2015/10/30 | 1,975 | 2,019 | 1,973 | 2,002 | +10 | +0.5% | 2,156,000 |
| 2015/10/29 | 2,030 | 2,048 | 1,979 | 1,992 | +2 | +0.1% | 1,375,000 |
| 2015/10/28 | 1,973 | 2,003 | 1,956 | 1,990 | +37 | +1.9% | 1,960,000 |
| 2015/10/27 | 1,964 | 1,987 | 1,943 | 1,953 | +10 | +0.5% | 1,274,000 |
| 2015/10/26 | 1,957 | 1,965 | 1,930 | 1,943 | +22 | +1.1% | 757,000 |
| 2015/10/23 | 1,953 | 1,959 | 1,915 | 1,921 | +7 | +0.4% | 1,798,000 |
| 2015/10/22 | 1,923 | 1,949 | 1,912 | 1,914 | -33 | -1.7% | 1,217,000 |
| 2015/10/21 | 1,931 | 1,956 | 1,894 | 1,947 | +16 | +0.8% | 1,425,000 |
| 2015/10/20 | 1,942 | 1,954 | 1,914 | 1,931 | +5 | +0.3% | 1,259,000 |
| 2015/10/19 | 1,890 | 1,972 | 1,885 | 1,926 | +27 | +1.4% | 2,062,000 |
| 2015/10/16 | 1,860 | 1,924 | 1,854 | 1,899 | +56 | +3% | 1,918,000 |
| 2015/10/15 | 1,782 | 1,852 | 1,773 | 1,843 | +96 | +5.5% | 2,081,000 |
| 2015/10/14 | 1,762 | 1,769 | 1,731 | 1,747 | -16 | -0.9% | 1,611,000 |
| 2015/10/13 | 1,724 | 1,770 | 1,724 | 1,763 | +48 | +2.8% | 1,645,000 |
| 2015/10/09 | 1,704 | 1,723 | 1,680 | 1,715 | +28 | +1.7% | 2,038,000 |
| 2015/10/08 | 1,748 | 1,748 | 1,683 | 1,687 | -75 | -4.3% | 1,697,000 |
| 2015/10/07 | 1,796 | 1,800 | 1,713 | 1,762 | -38 | -2.1% | 1,609,000 |
| 2015/10/06 | 1,801 | 1,805 | 1,777 | 1,800 | +1 | +0.1% | 1,319,000 |
| 2015/10/05 | 1,774 | 1,803 | 1,759 | 1,799 | +45 | +2.6% | 786,000 |
| 2015/10/02 | 1,755 | 1,770 | 1,740 | 1,754 | -6 | -0.3% | 754,000 |
| 2015/10/01 | 1,777 | 1,778 | 1,704 | 1,760 | -18 | -1% | 1,449,000 |
| 2015/09/30 | 1,730 | 1,797 | 1,724 | 1,778 | +128 | +7.8% | 2,203,000 |
| 2015/09/29 | 1,728 | 1,728 | 1,640 | 1,650 | -109 | -6.2% | 1,735,000 |
2301～
2350
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
